The immunophenotype of osteoclasts and macrophage polykaryons

Journal of Clinical Pathology

Volumn 64, Issue 8, 2011, Pages 701-705

  Maggiani, F ^a   Forsyth, R ^b   Hogendoorn, P C W ^c   Krenacs, T ^d   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD51 ANTIGEN; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE CYST; CHONDROBLASTOMA; CONTROLLED STUDY; FIBROMA; GIANT CELL; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MACROPHAGE; OSTEOCLAST; OSTEOSARCOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIGENS, CD; BONE AND BONES; BONE DISEASES; BONE NEOPLASMS; BONE REMODELING; GIANT CELL TUMOR OF BONE; GIANT CELLS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; OSTEOCLASTS;

EID: 79960739310     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2011.090852     Document Type: Article

References (46)

1. van Furth R. Cells of the mononuclear phagocyte system: nomenclature in terms of sites and conditions. In: van Furth R, ed. Mononuclear Phagocytes. The Hague: Martinus Nijhoff, 1980:1-30.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Rev Immunol 2005;5:953-64. (Pubitemid 41746764)
3. Athanasou NA. The cellular biology of bone-resorbing cells. J Bone Joint Surg Am 1996;78:1096-112.
4. Tanaka S, Takahashi N, Udagawa N, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-63. (Pubitemid 23037280)
5. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci U S A 1998;95:3597-602.
6. Quinn JM, Elliott J, Gillespie MT, et al. A combination of osteoclast differentiation factor and macrophage colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;139:4424-7. (Pubitemid 28513734)
7. Sutton JS, Weiss L. Transformation of monocytes in tissue culture into macrophages, epithelioid cells, and multinucleated giant cells. An electron microscope study. J Cell Biol 1966;28:303-32.
8. Chambers TJ. Multinucleate giant cells. J Pathol 1976;126:125-48. (Pubitemid 9062597)
9. Anderson JM. Multinucleated giant cells. Curr Opin Hematol 2000;7:40-7. (Pubitemid 30007686)
10. Chambers TJ, Horton MA. Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int 1984;36:556-8. (Pubitemid 15157109)
11. Marks SC Jr, Chambers TJ. The giant cells recruited by subcutaneous implants of mineralized bone particles and slices in rabbits are not osteoclasts. J Bone Miner Res 1991;6:395-400.
12. Athanasou NA, Quinn J, McGee JO. Leucocyte common antigen is present on osteoclasts. J Pathol 1987;153:121-6. (Pubitemid 17153986)
13. Athanasou NA, Quinn J. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 1990;43:997-1004.
14. Athanasou NA, Heryet A, Quinn J, et al. Osteoclasts contain macrophage and megakaryocyte antigens. J Pathol 1986;150:239-46. (Pubitemid 17211757)
15. Horton MA, Pringle JA, Chambers TJ. Identification of human osteoclasts with monoclonal antibodies. N Engl J Med 1985;312:923-4. (Pubitemid 15105686)
16. Horton MA, Lewis D, McNulty K, et al. Monoclonal antibodies to osteoclastoma (giant cell bone tumours): definition of osteoclast specific cellular antigens. Cancer Res 1985;45:5663-9. (Pubitemid 16218570)
17. Athanasou NA, Quinn J, Horton MA, et al. New sites of cellular vitrtonectin receptor or expression. Immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Miner 1990;8:7-22. (Pubitemid 20010630)
18. Kadoya Y, al-Saffar N, Kobayashi A, et al. The expression of osteoclast markers on foreign body giant cells. Bone Miner 1994;27:85-96.
19. Lau YS, Sabokbar A, Gibbons CL, et al. Phenotypic and molecular studies on giant cell tumours of bone and soft tissues. Hum Pathol 2005;36:945-54. (Pubitemid 41253379)
20. Quinn J, Sabokbar A, Athanasou NA. Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone-resorbing cells. J Pathol 1996;179:106-11. (Pubitemid 26180087)
21. Wang W, Ferguson DJ, Quinn JM, et al. Osteoclasts are capable of both phagocytosis and bone resorption. J Pathol 1997;182:92-8. (Pubitemid 27240454)
22. Faust J, Lacey DL, Hunt P, et al. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem 1999;72:67-80. (Pubitemid 28541482)
23. Fox SW, Fuller K, Bayley KE, et al. TGF-b and IFN-d direct macrohpage activation by TNF-a to osteoclastic or cytocidal phenotype. J Immunol 2000;165:4957-63.
24. Sorensen MG, Henriksen K, Schaller S, et al. Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 2007;25:36-45. (Pubitemid 46012995)
25. Lari R, Kitchener PD, Hamilton JA. The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res Ther 2009;11:R23.
26. Ritchlin C. The quest for a biomarker of circulating osteoclast precursors. Arthritis Res Ther 2009;11:R23.
27. Baydar D, Amin MB, Epstein JI. Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod Pathol 2006;19:161-71. (Pubitemid 43117600)
28. Denton HR, Stretch J, Athanasou NA. Osteoclast-like giant cells in metastatic malignant melanoma. Histopathology 1992;20:179-81.
29. Hamzei M, Ventriglia G, Hagnia M, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 2003;113:436-42. (Pubitemid 36292867)
30. Chun L, Yoon J, Song Y. The characterization of macrophages and osteoclasts in tissues harvested from revised total hip prostheses. J Biomed Mater Res 1999;48:899-903.
31. Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol 1999;31:539-44. (Pubitemid 29219400)
32. Nakamura I, Duong le T, Rodan SB, et al. Involvement of alpha (v) beta 3 integrins in osteoclast function. J Bone Miner Metab 2007;25:337-44.
33. Savill J, Dransfield I, Hogg N, et al. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990;343:170-3.
34. McNally AK, Anderson JM. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 2002;160:621-30. (Pubitemid 34160340)
35. Brodbeck WG, Anderson JM. Giant cell formation and function. Curr Opin Hematol 2009;16:53-7.
36. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;1289:1504-8.
37. Chambers TJ, Thomson BM, Fuller K. Effect of substrate composition on bone resorption by rabbit osteoclasts. J Cell Sci 1984;70:61-71. (Pubitemid 15220225)
38. Fuller K, Ross JL, Szewczyk KA, et al. Bone is not essential for osteoclast activation. PLoS One 2010;5:pii: e12837.
39. da Costa CE, Annels NE, Faaij CM. Presence of osteoclast-like multinucleated giant cells in the bone and monostotic lesions of Langerhans cell histiocytosis. J Exp Med 2005;291:687-93.
40. Huang L, Cheng YY, Chow LT, et al. Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment. Mol Pathol 2003;56:116-20. (Pubitemid 36461472)
41. Liu B, Yu SF, Li TJ. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 2003;32:367-75. (Pubitemid 36781536)
42. Balke M, Campanacci L, Gebert C, et al. Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer 2010;10:462.
43. Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010;11:275-80.
44. Mahendra G, Kliskey K, Athanasou NA. Immunophenotypic distinction between pigmented villonodular synovitis and haemosiderotic synovitis. J Clin Pathol 2010;63:75-8.
45. Flanagan AM, Chambers TJ. Osteoclasts are present in the giant cell variant of malignant fibrous histiocytoma. J Pathol 1989;159:53-7. (Pubitemid 19232107)
46. Taylor R, Kashima TG, Knowles H, et al. Osteoclast formation and function in pigmented villonodular synovitis. J Pathol 2011 (In press).